查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1832305

微生物檢測市場（按應用、技術、最終用戶、樣本類型和生物體類型）—2025-2032 年全球預測

Bacteriological Testing Market by Application, Technology, End User, Sample Type, Organism Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年細菌學檢測市場將成長至 291.1 億美元，複合年成長率為 11.10%。

主要市場統計數據
基準年2024年 125.4億美元
預計2025年 139.3億美元
預測年份：2032年 291.1億美元
複合年成長率（%） 11.10%

關於細菌學檢測如何在複雜的操作環境中支援健康保護、工業品質和臨床決策的權威概述

細菌學檢測處於公共衛生保護、工業品質保證和臨床決策的交匯點。有效的檢測策略可以降低疫情爆發風險，保護供應鏈，並支持醫療保健、食品生產、製藥、水務和環境監測項目的合規性。隨著微生物檢測方法的進步，相關人員如今期望快速的反應時間、更高的分析靈敏度以及清晰的解讀框架，以便快速採取行動。因此，實驗室和檢測供應商正在平衡技術投資與嚴格的品質體系，以滿足對可操作結果日益成長的需求。

本次應用評估概述了塑造現代細菌學檢測的核心促進因素：技術創新、監管壓力、跨部門風險管理和營運效率。實驗室正在將分子和定序技術整合到傳統的基於培養的工作流程中，環境和工業用戶需要可擴展的採樣方案，以滿足審核和認證需求。在這種演變的背景下，決策者必須優先考慮能力差距、員工能力和資料管治，以確保檢測仍然是預防、診斷和合規工作中值得信賴的支柱。

技術整合、監管趨嚴性和營運彈性如何將細菌檢測從診斷備份轉變為策略性風險管理能力

由於技術、監管和市場力量的融合，微生物檢測格局正在迅速變化，這些力量正在重塑組織檢測和管理微生物風險的方式。分子診斷技術的進步，例如更快的即時擴增和更便捷的定序，使得更早、更特異性檢測病原體成為可能。同時，自動化培養系統和改進的選擇性培養基正在減輕勞動力負擔，並提高常規監測的可重複性。這些互補的功能正在推動從純粹的確認性檢測向預測性和預防性應用的轉變，在這些應用中，數據可以為上游管理提供資訊。

監管要求和認證預期日益嚴格，促使實驗室網路和行業營運商投資檢驗的工作流程和強大的品管系統。環境監測計畫正從零星採樣轉向持續的、基於風險的策略，整合空氣、土壤、地表和水質檢測。該行業也在應對供應鏈壓力和對彈性採購模式的需求，重點關注互通性、數位化報告和模組化實驗室設計。總而言之，這些轉型正在提升細菌學檢測作為一項策略職能而非純粹的技術活動的作用。

分析近期關稅變化如何重塑美國細菌檢測相關人員的採購、供應商策略和業務連續性

2025年美國關稅計畫的變化正在影響細菌學檢測所用實驗室設備、耗材和試劑的採購籌資策略、全球供應鏈和成本結構。進口關稅和分類的更新可能會影響自動化設備、選擇性培養基、分子檢測套件和定序耗材的到岸成本，促使採購團隊重新評估整體擁有成本和供應商多元化。在許多情況下，實驗室主任和採購經理正在採用多供應商籌資策略並增加庫存緩衝，以便在關稅引發的價格波動期間保持檢測業務的連續性。

除了直接的成本影響外，關稅還加速了關於國內製造、戰略採購夥伴關係以及合約保護措施的討論，這些措施旨在降低關稅突然調整帶來的風險。相關人員也在重新審視設備標準化和互通性，以便在供應中斷時進行零件替換。因此，企業正在優先考慮供應商風險評估、涉及關稅轉嫁的合約條款以及情境規劃，以維持合規性和不間斷的檢測服務。這些調整反映了對政策主導的市場動態的務實應對，同時維護了其細菌檢測項目的完整性。

關鍵細分洞察揭示了不同應用、技術、最終用戶、樣本類型和生物分類的優先順序差異，從而實現有針對性的決策

細分主導的洞察揭示了不同應用領域、技術類型、最終用戶、樣本類型和生物群體在測試優先順序、技術採用和服務交付模式方面存在巨大差異。臨床診斷強調診斷的準確性和速度；體外診斷和 POC 測試優先考慮快速分子和免疫檢測方法，而實驗室開發的測試為利基病原體提供了靈活性。環境監測要求在強調長期監測的空氣品質採樣和土壤測試技術之間取得平衡；食品和飲料安全計劃側重於乳製品、肉類和已調理食品基質，需要培養確認和快速檢測以保持供應鏈的完整性。製藥和生物技術用戶要求對最終產品和成分進行經過驗證的測試，以符合嚴格的監管要求；水質檢測涵蓋飲用水和污水通訊協定，以支持公共衛生和公共產業合規性。

從技術角度來看，培養檢測仍然是確認和敏感性分析的基礎，並透過自動化系統和選擇性培養基進行增強以提高通量。免疫檢測廣泛用於篩檢，酵素結合免疫吸附試驗和橫向流動形式在靈敏度和易操作性之間提供了不同的權衡。下一代定序透過靶向和全基因組方法提供生物體的詳細表徵，從而實現疫情取證和抗藥性菌株追蹤，而數位 PCR 和即時PCR等聚合酵素鏈鎖反應形式則以定量準確性加速檢測。快速檢測平台，無論是快速免疫檢測或快速分子檢測法，都支援近患者和現場決策。環境機構和水質淨化水廠優先考慮合規性和環境監測；食品加工廠強調污染預防和產品放行測試；醫院和診斷實驗室優先考慮臨床敏感性和工作流程整合；製藥商要求進行嚴格的驗證。樣本類型（血液、食物基質、表面拭子、尿液、水）決定了採樣通訊協定、分析前處理和分析方法的選擇，而細菌、真菌、寄生蟲和病毒的生物型分類則決定了檢測設計和解讀標準。了解這些層級分類有助於組織協調投資、最佳化方法選擇，並設計出符合營運和監管目標的採樣方案。

細緻地檢查不同地區在優先事項和基礎設施方面的差異如何導致細菌學檢測的採用和能力建設方面的差異。

區域動態正在影響全球細菌學檢測的優先順序、資金投入和監管方式，不同地域市場呈現不同的促進因素和採用模式。在美洲，相關人員優先考慮快速採用先進的診斷技術和綜合實驗室網路，以支援公共衛生監測和成熟的私人醫療保健部門。實驗室現代化和商業性診斷合作夥伴關係的投資很常見，法律規範也在不斷改進，以應對新出現的微生物威脅。在歐洲、中東和非洲，不同夥伴關係在監管協調、能力建設和基礎設施方面的投資差異很大，一些國家大力推行標準化品管，而另一些國家則優先考慮基本的監測和培訓計畫。跨境合作和資金投入是擴大偵測管道和加強該地區疫情防範的重要槓桿。

亞太地區的特點是自動化培養系統、分子診斷和大規模環境監測計畫的快速應用，其需求在工業擴張和都市化推動下呈現多元化但快速成長的態勢。該地區的多個市場正在大力投資本地生產和勞動力發展，以支持國內檢測能力並減少對進口的依賴。在整個地區，資料系統的互通性、數位化報告和統一的檢驗實踐正成為跨轄區監控和事件回應的核心。這些區域洞察凸顯了製定能夠反映當地法規環境、資源限制和公共衛生優先事項的客製化部署策略的必要性。

深入了解成功的細菌學檢測公司的競爭策略、合作模式和營運重點

關鍵公司洞察凸顯了細菌檢測領域成功企業在競爭和擴張方面所採用的策略方法。市場領先的公司通常將強大的研發能力與有針對性的夥伴關係相結合，以擴展其檢測產品組合併加快產品上市速度。許多公司也正在投資模組化實驗室平台和數位彙報解決方案，以促進互通性並簡化不同終端用戶的部署。策略性收購仍然是獲取利基技術、擴大地域覆蓋範圍以及填補定序、自動化和快速檢測領域能力缺口的常見途徑。

服務供應商和合約測試實驗室憑藉其專業的應用專長、快速的周轉時間以及符合客戶和監管要求的認證品質體系，脫穎而出。提供全面技術支援、培訓計劃和檢驗的工作流程的供應商往往能夠深入滲透醫院、營業單位和製藥商等機構客戶。此外，在關稅和物流波動威脅業務連續性的時期，專注於本地化製造和供應鏈彈性的公司正在獲得發展。總而言之，這些競爭態勢表明，技術廣度、監管合規性和以客戶為中心的服務模式能夠帶來顯著的市場優勢。

領導者可以實施的具體、優先建議，以增強實驗室的彈性，提高檢測效能，並確保監管準備就緒

產業領導者可以採取明確可行的措施，增強實驗室的韌性，提升檢測能力，並使檢測項目與策略目標保持一致。優先投資整合分子和基於培養的方法，以平衡速度和確認的確定性，並採用經過檢驗的通訊協定標準化工作流程，以簡化培訓並減少差異性。加強供應商關係，並圍繞定價和供應連續性實施合約保障措施，以降低與關稅和全球物流相關的中斷風險​​。同時，投資數據互通性和數位化彙報，將偵測結果轉化為支持事件回應和持續改進的及時情報。

員工隊伍建立同樣重要。有針對性的培訓、交叉培訓和能力評估使負責人能夠操作先進的平台並解讀複雜的分子或定序結果。實施基於風險的採樣框架可以透過將檢測重點放在高影響矩陣和關鍵控制點上來最佳化資源配置。最後，與監管機構和認證機構保持積極溝通，預測變化，並主動定位檢測項目，以促進合規和公共衛生夥伴關係。這些策略行動使組織能夠將檢測能力轉化為可證明的商業價值和聲譽。

混合方法研究設計的透明描述，結合專家訪談、監管審查和技術映射，以獲得可行的見解

本分析背後的調查方法融合了定性和定量分析，以確保研究的穩健性和有效性。主要研究包括訪談實驗室管理人員、品管、採購負責人以及臨床、環境、食品安全、製藥和水務領域的專家，以獲得第一手的營運挑戰和技術偏好洞察。次要研究則檢視了監管指南、標準、同行評審文獻、行業出版物和公開的技術文檔，以檢驗趨勢和技術發展。

此分析框架整合了技術採用情況圖譜、應用和最終用戶細分分析以及供應商能力評估，以整合橫向洞察。我們進行了資料來源三角檢驗，並與業界從業者進行了迭代檢驗，以最大程度地減少偏差並提高實際適用性。這項流程確保研究結果能夠反映營運實際情況、產業差異以及細菌學檢測領域的最新方法進展，而無需依賴推測性預測模型。

結論性總結強調了綜合檢查方法、供應彈性和持續的作戰安全人員準備的戰略重要性

總而言之，細菌學檢測正在從一項確認性檢測功能發展成為一項策略能力，為多個部門的預防、合規和營運決策提供資訊。技術融合——分子診斷、定序和自動化技術對傳統培養方法的補充——使得檢測速度更快、更準確，同時也提高了對品質系統和員工能力的期望。政策和供應鏈動態，例如不斷變化的關稅和採購壓力，迫使企業重新評估其採購、庫存策略和供應商關係，以確保業務連續性並控制成本。

為了在不斷變化的環境中保持高效，相關人員必須採用整合的檢測策略，使方法選擇與應用需求保持一致，投資於互通性和數據驅動的工作流程，並與監管機構和行業合作夥伴保持積極主動的溝通。如此一來，組織不僅可以提高檢測和應對微生物風險的能力，還能將檢測轉化為對營運韌性和公共衛生保護的可衡量貢獻。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 將快速核酸增幅檢查整合到照護現場診斷工作流程中
  • 引進自動化、高性能細菌培養系統以提高實驗室效率
  • 臨床實驗室對結合細菌學和病毒學檢測的多病原體檢測的需求日益增加
  • 人工智慧演算法在細菌敏感性數據自動解釋的應用
  • 人們對數微流體在照護端快速抗生素抗藥性分析中的興趣日益濃厚
  • 社區層級細菌病原體監測趨勢日益重視廢水監測
  • 透過診斷實驗室和醫院之間的合作，在農村地區開發分散的細菌檢測平台
  • 擴大次世代定序在細菌感染叢集流行病學追蹤的應用

第6章 2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章微生物檢測市場的應用

  • 臨床診斷
    • 體外診斷
    • 實驗室開發的測試
    • 就地檢驗
  • 環境監測
    • 空氣品質
    • 土壤樣本採集
  • 食品和飲料安全
    • 乳製品
    • 肉品
    • 即食產品
  • 製藥和生物技術
    • 最終產品
    • 原料
  • 水質檢測
    • 飲用水
    • 污水

第9章微生物檢測市場（依技術）

  • 文化測試
    • 自動化系統
    • 選擇性培養基
  • 免疫檢測
    • 酵素結合免疫吸附試驗
    • 橫向流動化驗
  • 下一代定序
    • 目標序列
    • 全基因組序列分析
  • 聚合酵素鏈鎖反應
    • 數位PCR
    • 即時PCR
  • 快速檢測
    • 快速免疫檢測
    • 快速分子測量

第 10 章微生物學檢測市場（按最終用戶分類）

  • 環境機構
  • 食品加工設施
  • 醫院和診斷實驗室
  • 製藥商
  • 水處理廠

第 11 章微生物學檢測市場（依樣本類型）

  • 血液樣本
  • 食品樣品
  • 表面拭子
  • 尿液樣本
  • 水樣

第 12 章微生物檢測市場（依生物體類型）

  • 細菌
  • 真菌
  • 寄生蟲
  • 病毒

第13章微生物檢測市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章微生物檢測市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國微生物檢測市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Thermo Fisher Scientific, Inc.
    • Danaher Corporation
    • bioMerieux SA
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Siemens Healthineers AG
    • QIAGEN NV
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
Product Code: MRR-437D45957E5D

The Bacteriological Testing Market is projected to grow by USD 29.11 billion at a CAGR of 11.10% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 12.54 billion
Estimated Year [2025] USD 13.93 billion
Forecast Year [2032] USD 29.11 billion
CAGR (%) 11.10%

An authoritative overview of how bacteriological testing underpins health protection, industrial quality, and clinical decision-making in complex operational environments

Bacteriological testing stands at the intersection of public health protection, industrial quality assurance, and clinical decision-making. Effective testing strategies reduce outbreak risks, safeguard supply chains, and support regulatory compliance across healthcare, food production, pharmaceutical manufacturing, water utilities, and environmental monitoring programs. As microbial detection methodologies have advanced, stakeholders now expect faster turnaround, greater analytical sensitivity, and clearer interpretation frameworks to inform rapid action. Consequently, laboratories and testing providers are balancing investments in technology with rigorous quality systems to meet the rising demand for actionable results.

This introduction outlines core drivers shaping contemporary bacteriological testing: technological innovation, regulatory pressure, cross-sector risk management, and operational efficiency. Laboratories are integrating molecular and sequencing techniques into traditional culture-based workflows, while environmental and industrial users require scalable sampling programs that align with audit and certification needs. Against this evolving backdrop, decision-makers must prioritize capability gaps, workforce competency, and data governance to ensure testing remains a reliable pillar of prevention, diagnosis, and compliance efforts.

How technological convergence, regulatory tightening, and operational resilience are transforming bacteriological testing from diagnostic backstop to strategic risk management capability

The landscape of bacteriological testing has shifted rapidly due to converging technological, regulatory, and market forces that are reshaping how organizations detect and manage microbial risks. Advances in molecular diagnostics, including faster real-time amplification and more accessible sequencing, are enabling earlier and more specific detection of pathogens. At the same time, automated culture systems and improved selective media are reducing labor burden and enhancing reproducibility for routine surveillance. These complementary capabilities are catalyzing a transition from purely confirmatory testing to predictive and preventive applications where data informs upstream controls.

Regulatory requirements and accreditation expectations have tightened, prompting laboratory networks and industrial operators to invest in validated workflows and robust quality management systems. Environmental monitoring programs are moving from sporadic sampling to continuous, risk-based strategies that integrate air, soil, surface, and water testing. The industry is also responding to supply chain pressures and the need for resilient procurement models, with an emphasis on interoperability, digital reporting, and modular laboratory design. Taken together, these transformative shifts are elevating the role of bacteriological testing as a strategic function rather than a purely technical activity.

An analysis of how recent tariff shifts are reshaping procurement, supplier strategies, and operational continuity for bacteriological testing stakeholders in the United States

Tariff policy changes in the United States for 2025 are influencing procurement strategies, global supply chains, and cost structures for laboratory equipment, consumables, and reagents used in bacteriological testing. Import duties and classification updates can affect the landed cost of automated instruments, selective media, molecular assay kits, and sequencing consumables, prompting procurement teams to reassess total cost of ownership and vendor diversification. In many cases, laboratory directors and procurement managers are adopting multi-vendor sourcing strategies and increasing inventory buffers to maintain continuity of testing operations during periods of tariff-driven price volatility.

Beyond direct cost implications, tariffs are accelerating conversations around domestic manufacturing, strategic sourcing partnerships, and contractual protections that mitigate exposure to sudden tariff adjustments. Stakeholders are also revisiting instrument standardization and cross-compatibility to enable substitution of components when supply disruption occurs. As a result, organizations increasingly prioritize supplier risk assessments, contractual clauses that address tariff pass-through, and scenario planning to maintain compliance and uninterrupted testing services. These adaptive measures reflect a pragmatic response to policy-driven market dynamics while preserving the integrity of bacteriological testing programs.

Essential segmentation insights that illuminate differential priorities across applications, technologies, end users, sample types, and organism classifications for targeted decision making

Segmentation-driven insights reveal substantive differences in testing priorities, technology adoption, and service delivery models across application areas, technology types, end users, sample types, and organism groups. In clinical diagnostics, the focus centers on diagnostic accuracy and speed, with in vitro diagnostics and point of care testing prioritizing rapid molecular and immunoassay approaches, while laboratory developed tests provide flexibility for niche pathogens. Environmental monitoring requires a balance of air quality sampling and soil testing techniques that emphasize longitudinal surveillance, and food and beverage safety programs concentrate on dairy, meat, and ready-to-eat matrices that demand both culture confirmation and rapid detection to preserve supply chain integrity. Pharmaceutical and biotech users demand validated testing for final products and raw materials that align with stringent regulatory expectations, and water testing spans drinking water and wastewater protocols that support public health and utility compliance.

From a technology perspective, culture testing remains foundational for confirmation and susceptibility profiling, augmented by automated systems and selective media to improve throughput. Immunoassays are used widely for screening, with enzyme linked immunosorbent assays and lateral flow formats delivering different trade-offs between sensitivity and operational simplicity. Next generation sequencing provides deep characterization of organisms through targeted and whole genome approaches, enabling outbreak forensics and resistance tracking, while polymerase chain reaction modalities such as digital and real time PCR accelerate detection with quantitative precision. Rapid detection platforms, whether rapid immunoassay or rapid molecular, are enabling near-patient and on-site decision making. End users vary widely in capability and need: environmental agencies and water treatment plants often emphasize compliance and ambient surveillance, food processing facilities focus on contamination prevention and product release testing, hospitals and diagnostic laboratories prioritize clinical sensitivity and workflow integration, and pharmaceutical manufacturers require tightly validated processes. Sample type considerations-blood, food matrices, surface swabs, urine, and water-drive sampling protocols, pre-analytical handling, and method selection, while organism type classification among bacteria, fungi, parasites, and viruses informs assay design and interpretive criteria. Understanding these layered segmentations helps organizations tailor investments, optimize method selection, and design sampling programs that meet both operational and regulatory objectives.

A nuanced exploration of how distinct regional priorities and infrastructure differences are driving variation in bacteriological testing adoption and capability development

Regional dynamics are shaping how bacteriological testing is prioritized, funded, and regulated across the globe, with geographic markets exhibiting distinct drivers and adoption patterns. In the Americas, stakeholders emphasize rapid adoption of advanced diagnostics and integrated laboratory networks that support public health surveillance and a mature private healthcare sector. Investment in laboratory modernization and commercial diagnostic partnerships is common, and regulatory frameworks are continually refined to address emerging microbial threats. In Europe, the Middle East and Africa, regulatory harmonization, capacity building, and infrastructure investment vary considerably across jurisdictions, with some countries driving strong adoption of standardized quality management while others prioritize foundational surveillance and training programs. Cross-border collaboration and funding initiatives are important levers for expanding testing access and strengthening outbreak preparedness in the region.

The Asia-Pacific region demonstrates heterogeneous but fast-moving demand, characterized by rapid uptake of automated culture systems, molecular diagnostics, and large-scale environmental monitoring programs driven by industrial expansion and urbanization. Several markets in the region are investing heavily in local manufacturing and workforce training to support domestic testing capacity and reduce reliance on imports. Across all regions, interoperability of data systems, digital reporting, and harmonized validation practices are becoming central to cross-jurisdictional surveillance and incident response. These regional insights underscore the need for tailored deployment strategies that reflect local regulatory environments, resource constraints, and public health priorities.

Insightful analysis of competitive strategies, partnership models, and operational priorities that distinguish successful companies in bacteriological testing

Key company insights underscore strategic approaches that successful organizations use to compete and scale within the bacteriological testing landscape. Market leaders often combine strong R&D capabilities with targeted partnerships to broaden assay portfolios and accelerate time to market. Many also invest in modular laboratory platforms and digital reporting solutions that facilitate interoperability and ease of adoption across diverse end users. Strategic acquisitions remain a common pathway to acquiring niche technologies, expanding geographical footprints, and filling capability gaps in sequencing, automation, or rapid detection.

Service providers and contract laboratories differentiate through specialized application expertise, rapid turnaround times, and accredited quality systems that meet customer and regulator expectations. Suppliers that offer comprehensive technical support, training programs, and validated workflows tend to achieve deeper penetration into institutional customers such as hospitals, water utilities, and pharmaceutical manufacturers. Additionally, companies focusing on localized manufacturing and supply chain resilience are gaining traction where tariff or logistical volatility threatens continuity. Collectively, these competitive behaviors reflect a market where technology breadth, regulatory alignment, and customer-centric service models provide meaningful advantage.

Concrete and prioritized recommendations that leaders can implement to fortify laboratory resilience, improve detection performance, and ensure regulatory readiness

Industry leaders can take clear, actionable steps to strengthen laboratory resilience, improve detection capabilities, and align testing programs with strategic goals. Prioritize investments that integrate molecular and culture-based methods to balance speed with confirmatory certainty, and standardize workflows with validated protocols to streamline training and reduce variability. Strengthening supplier relationships and implementing contractual safeguards around pricing and supply continuity will mitigate disruption risks related to tariffs and global logistics. In parallel, invest in data interoperability and digital reporting to transform test results into timely intelligence that supports incident response and continuous improvement.

Workforce development is equally important; targeted training, cross-training, and competency assessments ensure that personnel can operate advanced platforms and interpret complex molecular or sequencing outputs. Implementing risk-based sampling frameworks will optimize resource allocation by focusing testing on high-impact matrices and critical control points. Finally, maintain active engagement with regulators and accreditation bodies to anticipate changes and position testing programs proactively for compliance and public health partnerships. These strategic actions enable organizations to convert testing capability into demonstrable operational and reputational value.

A transparent explanation of the mixed methods research design combining expert interviews, regulatory review, and technology mapping to derive actionable insights

The research methodology underpinning this analysis blends qualitative and quantitative approaches to ensure robustness and relevance. Primary interviews were conducted with laboratory directors, quality managers, procurement officers, and subject matter experts across clinical, environmental, food safety, pharmaceutical, and water sectors to capture firsthand operational challenges and technology preferences. Secondary research included a review of regulatory guidance, standards, peer-reviewed literature, trade publications, and publicly available technical materials to validate trends and technological developments.

Analytical frameworks incorporated technology adoption mapping, segmentation analysis by application and end user, and supplier capability assessments to synthesize cross-cutting insights. Triangulation of data sources and iterative validation with industry practitioners were used to minimize bias and enhance practical applicability. Throughout the process, care was taken to ensure that findings reflect operational realities, sectoral nuances, and the latest methodological advances in bacteriological testing without relying on speculative forecasting models.

A decisive wrap-up highlighting the strategic importance of integrated testing approaches, supply resilience, and workforce readiness for sustained operational security

In conclusion, bacteriological testing is evolving from a confirmatory laboratory function into a strategic capability that informs prevention, compliance, and operational decision making across multiple sectors. Technology convergence-where molecular diagnostics, sequencing, and automation complement traditional culture methods-is enabling faster, more precise detection while also raising expectations around quality systems and workforce competency. Policy and supply chain dynamics, including tariff shifts and procurement pressures, are prompting organizations to rethink sourcing, inventory strategies, and supplier relationships to protect continuity and manage costs.

To remain effective in this changing environment, stakeholders must adopt integrated testing strategies that align method selection with application needs, invest in interoperability and data-driven workflows, and maintain proactive engagement with regulators and industry partners. By doing so, organizations will not only improve their capacity to detect and respond to microbial risks but also transform testing into a measurable contributor to operational resilience and public health protection.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of rapid nucleic acid amplification tests in point-of-care diagnostic workflows
  • 5.2. Adoption of automated high-throughput bacterial culture systems to improve lab efficiency
  • 5.3. Growing demand for multiplex pathogen assays combining bacteriological and viral detection in clinical labs
  • 5.4. Implementation of artificial intelligence algorithms for automated interpretation of bacterial susceptibility data
  • 5.5. Rising interest in digital microfluidics for rapid antibiotic resistance profiling at the point of care
  • 5.6. Increasing focus on wastewater surveillance for community-level bacteriological pathogen monitoring trends
  • 5.7. Collaboration between diagnostics labs and hospitals to deploy decentralized bacteriological testing platforms in rural areas
  • 5.8. Expansion of next generation sequencing applications for epidemiological tracking of bacterial outbreak clusters

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bacteriological Testing Market, by Application

  • 8.1. Clinical Diagnostics
    • 8.1.1. In Vitro Diagnostics
    • 8.1.2. Laboratory Developed Tests
    • 8.1.3. Point Of Care Testing
  • 8.2. Environmental Monitoring
    • 8.2.1. Air Quality
    • 8.2.2. Soil Sampling
  • 8.3. Food And Beverage Safety
    • 8.3.1. Dairy Products
    • 8.3.2. Meat Products
    • 8.3.3. Ready To Eat Products
  • 8.4. Pharmaceutical And Biotech
    • 8.4.1. Final Products
    • 8.4.2. Raw Materials
  • 8.5. Water Testing
    • 8.5.1. Drinking Water
    • 8.5.2. Wastewater

9. Bacteriological Testing Market, by Technology

  • 9.1. Culture Testing
    • 9.1.1. Automated Systems
    • 9.1.2. Selective Media
  • 9.2. Immunoassay
    • 9.2.1. Enzyme Linked Immunosorbent Assay
    • 9.2.2. Lateral Flow Assay
  • 9.3. Next Generation Sequencing
    • 9.3.1. Targeted Sequencing
    • 9.3.2. Whole Genome Sequencing
  • 9.4. Polymerase Chain Reaction
    • 9.4.1. Digital PCR
    • 9.4.2. Real Time PCR
  • 9.5. Rapid Detection
    • 9.5.1. Rapid Immunoassay
    • 9.5.2. Rapid Molecular

10. Bacteriological Testing Market, by End User

  • 10.1. Environmental Agencies
  • 10.2. Food Processing Facilities
  • 10.3. Hospitals And Diagnostic Laboratories
  • 10.4. Pharmaceutical Manufacturers
  • 10.5. Water Treatment Plants

11. Bacteriological Testing Market, by Sample Type

  • 11.1. Blood Samples
  • 11.2. Food Samples
  • 11.3. Surface Swabs
  • 11.4. Urine Samples
  • 11.5. Water Samples

12. Bacteriological Testing Market, by Organism Type

  • 12.1. Bacteria
  • 12.2. Fungi
  • 12.3. Parasites
  • 12.4. Viruses

13. Bacteriological Testing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bacteriological Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bacteriological Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific, Inc.
    • 16.3.2. Danaher Corporation
    • 16.3.3. bioMerieux SA
    • 16.3.4. F. Hoffmann-La Roche AG
    • 16.3.5. Abbott Laboratories
    • 16.3.6. Siemens Healthineers AG
    • 16.3.7. QIAGEN N.V.
    • 16.3.8. Becton, Dickinson and Company
    • 16.3.9. Bio-Rad Laboratories, Inc.
    • 16.3.10. Merck KGaA

LIST OF FIGURES

  • FIGURE 1. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BACTERIOLOGICAL TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BACTERIOLOGICAL TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BACTERIOLOGICAL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY GROUP, 2025-2032 (USD MILLION